AESTYVE FILLER is produced by the well-known Pharmaceutical
in South Korea. With the development of the medical beauty
industry After years of rigorous clinical trials it has developed
anti-premature products.
|
Mechanism of Action
|
1. Hyaluronic Acid : EP Grade 2. ZeroEndotoxin Process : The content of Endotoxin is lower than EU criteria, the BDDE residue is close to zero,and there is no side effects occurred after the surgery. 3. Cross-Linking : By improving the cross-linking method, AESTYVE achieved the most complete cross-linking state with the minimum amount of BDDE investment. 4. DowningProcessTechnology : With Downing Process Technology, the resistance to injection becomes less and plasticity becomes higher. 5. Viscosity&Elasticity : ESSES is monophasic filler with high viscosity and elasticity. It's high cohesion makes it difficult to diffuse in the skin tissue layer, and more stable positioning. 6. PH&osmolality : The PH&osmolality is close to the human body so that it reduce pain and foreign body sensation after injection. |
|
Expected Effects
|
• Alpha: Improvement of fine lines, tear troughs, and wrinkles • Beta: Medium-sized skin depressions, enhancement of the Lip area • Gamma: Face contouring, nose and chin volume augmentation |
|
Benefits |
• HA cross-linking • Forming a HA structure • High VIscoSity • Hard to displace • Stable positioning • Longlasting |
